Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: medac, Gesellschaft für klinische, Spezialpräparate mbH, Theaterstr. 6, 22880, Wedel, Germany
Levofolinic acid 50 mg/ml solution for injection/infusion.
Pharmaceutical Form |
---|
Solution for injection/infusion. Slightly yellow, clear solution. |
Each ml of solution contains 54.65 mg disodium levofolinate equivalent to 50 mg levofolinic acid.
Each 1 ml vial contains 54.65 mg disodium levofolinate equivalent to 50 mg levofolinic acid.
Each 4 ml vial contains 218.6 mg disodium levofolinate equivalent to 200 mg levofolinic acid.
Each 9 ml vial contains 491.85 mg disodium levofolinate equivalent to 450 mg levofolinic acid.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Levoleucovorin |
Levoleucovorin is the pharmacologically active isomer of 5-formyltetrahydrofolic acid. Administration of levoleucovorin can “rescue” normal cells and thereby prevent toxicity of folic acid antagonists such as methotrexate which act by inhibiting dihydrofolate reductase. |
List of Excipients |
---|
Sodium hydroxide (for pH-adjustment) |
Colourless glass vials type I with bromobutyl rubber stoppers and aluminium flip-off caps.
Pack sizes: Vials with 1 ml, 4 ml, or 9 ml solution for injection/infusion in packs of 1 or 5 vials. Not all pack sizes may be marketed.
medac, Gesellschaft für klinische, Spezialpräparate mbH, Theaterstr. 6, 22880, Wedel, Germany
PL 11587/0042
Date of first authorisation: 19/03/2008
Date of latest renewal: 06/03/2013
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.